Biotechnology November 10, 2021 Arbor Biotechnologies raises $215m through Series B round By PBR Staff Writer With this round, the biotechnology firm has raised more than $300m so far. The funding round was led by Ally Bridge Group, TCG Crossover, and Temasek. Among the
Research & DevelopmentDrug Discovery November 2, 2021 Synthekine, Merck partner to develop new cytokine-based therapies By PBR Staff Writer Synthekine and Merck have signed a global research collaboration and license agreement to develop novel cytokine-based therapeutics. As part of the collaboration, the companies will discover, develop, and
RegulationApprovals November 1, 2021 FDA provides EUA for Pfizer-BioNTech’s Covid-19 vaccine in children By PBR Staff Writer The US Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for Pfizer-BioNTech’s Covid-19 vaccine for children aged 5 to 11 years. The 10-µg vaccine doses
Drug Delivery October 29, 2021 Pfizer, BioNTech to supply Covid-19 vaccine paediatric doses to US By PBR Staff Writer Pfizer and its partner BioNTech have announced that the US government has purchased additional paediatric doses of their Covid-19 vaccine, as it prepares for paediatric vaccinations. Under the
Drug Discovery May 12, 2021 Lilly, MiNA Therapeutics partner to develop new drug candidates By vbandhakavi The companies will leverage MiNA Therapeutics’ small activating RNA (saRNA) technology platform to develop the drug candidates. Using its saRNA platform, MiNA Therapeutics will research up to five
RegulationClinical TrialsHuman Trials February 1, 2021 AstraZeneca secures conditional marketing authorisation for Covid-19 vaccine in Europe By PBR Staff Writer The authorisation was granted after the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency reviewed the primary data from the vaccine’s Phase III
Cell Culture and Cell TherapyRespiratoryResearch and Development (RD) January 29, 2021 GE researchers begin in-depth study to understand Covid-19 impact on lungs By PBR Staff Writer The study aims to identify the types of lung cells targeted by the virus and the resulting reaction due to the infection. In some of the most severe
Clinical TrialsHuman Trials January 13, 2021 GSK, Vir Biotechnology to evaluate neutralising Covid-19 antibody in AGILE study By PBR Staff Writer VIR-7832, a neutralising Covid-19 antibody, attaches to an epitope on SARS-CoV-2 that is shared with SARS-CoV-1. According to GSK, the preclinical data suggests that VIR-7832 has two distinguishing
Drug DiscoveryResearch & Development January 12, 2021 Sanofi to buy biopharmaceutical firm Kymab for up to $1.45bn By PBR Staff Writer As per terms of the deal, Kymab will secure an upfront payment of up to $1.1bn from Sanofi. Kymab is also eligible to secure up to $350m based
Drug DiscoveryResearch & Development January 11, 2021 Affinivax secures $226m in Series C financing to boost MAPS vaccine pipeline By PBR Staff Writer The company has pooled funds in a financing round co-led by new investors Rock Springs Capital and Foresite Capital. Other new investors consist of T. Rowe Price, Wellington